Filana Therapeutics, Inc. Increase (Decrease) in Other Current Liabilities
Filana Therapeutics, Inc. (FLNA) reported Increase (Decrease) in Other Current Liabilities of -$396.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2023-08-03
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2023-06-30 was -$83.00K, a 171.55% decline year-over-year.
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2023-03-31 was -$313.00K.
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2022-12-31 was $76.00K, a 37.70% decline year-over-year.
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2022-09-30 was $42.00K, a 93.57% decline year-over-year.
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2022 was -$136.00K, a 118.60% decline from fiscal 2021.
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2021 was $731.00K, a 760.00% increase from fiscal 2020.
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2020 was $85.00K, a 844.44% increase from fiscal 2019.
- Filana Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2019 was $9.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$396.00K 10-Q · filed 2023-08-03 | -$320.00K derived: sum of 3 quarters · filed 2023-08-03 | -$278.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | -$313.00K 10-Q · filed 2023-05-01 | -$237.00K derived: sum of 2 quarters · filed 2023-05-01 | -$195.00K derived: sum of 3 quarters · filed 2023-05-01 | -$79.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $118.00K derived: sum of 2 quarters · filed 2023-02-28 | $234.00K derived: sum of 3 quarters · filed 2023-08-03 | -$136.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $158.00K derived: sum of 2 quarters · filed 2023-08-03 | -$212.00K 10-Q · filed 2022-11-07 | -$90.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$254.00K 10-Q · filed 2023-08-03 | -$132.00K derived: sum of 3 quarters · filed 2023-08-03 | $521.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$370.00K 10-Q · filed 2023-05-01 | -$248.00K derived: sum of 2 quarters · filed 2023-05-01 | $405.00K derived: sum of 3 quarters · filed 2023-05-01 | $405.00K derived: sum of 4 quarters · filed 2023-05-01 |
| 2021-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $775.00K derived: sum of 2 quarters · filed 2023-02-28 | $775.00K derived: sum of 3 quarters · filed 2023-02-28 | $731.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $653.00K derived: sum of 2 quarters · filed 2022-11-07 | $609.00K 10-Q · filed 2022-11-07 | $696.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$44.00K 10-Q · filed 2022-08-04 | $43.00K derived: sum of 3 quarters · filed 2023-02-28 | $36.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$44.00K 10-Q · filed 2022-05-05 | $43.00K derived: sum of 2 quarters · filed 2023-02-28 | $36.00K derived: sum of 3 quarters · filed 2023-02-28 | $39.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $80.00K derived: sum of 2 quarters · filed 2023-02-28 | $83.00K derived: sum of 3 quarters · filed 2023-02-28 | $85.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$4.00K derived: sum of 2 quarters · filed 2021-11-15 | -$2.00K 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $5.00K 10-Q · filed 2021-08-04 | $7.00K derived: sum of 3 quarters · filed 2021-08-04 | $0.00 derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $2.00K 10-Q · filed 2021-04-29 | $4.00K derived: sum of 2 quarters · filed 2021-04-29 | -$3.00K derived: sum of 3 quarters · filed 2021-04-29 | -$1.00K derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$5.00K derived: sum of 2 quarters · filed 2021-03-23 | -$3.00K derived: sum of 3 quarters · filed 2021-03-23 | $9.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$5.00K derived: sum of 2 quarters · filed 2020-11-09 | $7.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $14.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $12.00K 10-Q · filed 2020-05-06 | |||
| 2018-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$2.00K derived: sum of 2 quarters · filed 2019-10-29 | $8.00K 10-Q · filed 2019-10-29 | |
| 2018-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $12.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $10.00K 10-Q · filed 2019-05-02 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | -$3.00K 10-K · filed 2017-03-07 | ||
| 2014-09-30 | -$3.00K 10-Q · filed 2015-11-09 | |||
| 2013-12-31 | -$21.00K 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |